Screener
Perspective Therapeutics CATX Gross Profit
Discontinued — last reported Q3 '23
Gross Profit at other companies
Other financials
Where this comes from
Calculated from Perspective Therapeutics’s reported figures.
The source filing: Perspective Therapeutics’s 10-Q, filed November 14, 2023.
- Filed
- Nov 14, 2023, 4:59 PM EST
- Fiscal quarter
- Q3 FY2023
- Calendar quarter
- Q3 2023
- Accession
- 0001437749-23-032036
| Line item | Three months ended / September 30, 2023 | Three months ended / September 30, 2022 | Nine months ended / September 30, 2023 | Nine months ended / September 30, 2022 |
|---|---|---|---|---|
| Grant revenue | 276 | - | 1,097 | - |
| Total revenue | 2,185 | 1,717 | 6,336 | 7,132 |
| Cost of sales | 1,447 | 1,303 | 4,863 | 4,351 |
| Gross profit | 738 | 414 | 1,473 | 2,781 |
| Operating expenses: | ||||
| Research and development | 5,721 | 708 | 15,231 | 2,053 |
| Sales and marketing | 855 | 800 | 2,578 | 2,141 |
| General and administrative | 4,696 | 3,114 | 16,792 | 6,277 |
ITEM 1 - FINANCIAL STATEMENTS
FAQ
- What is Perspective Therapeutics's gross profit?
- Perspective Therapeutics (CATX) reported gross profit of $738K in Q3 2023.
- How has Perspective Therapeutics's gross profit changed year-over-year?
- Perspective Therapeutics's gross profit increased by 78.3% year-over-year, from $414K to $738K.
- What does gross profit mean?
- Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.
Ask your AI about Perspective Therapeutics's gross profit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude